Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Surgical Trial In Traumatic intraCerebral Haemorrhage
ISRCTN ISRCTN19321911
ClinicalTrials.gov identifier
Public title Surgical Trial In Traumatic intraCerebral Haemorrhage
Scientific title Surgical Trial In Traumatic intraCerebral Haemorrhage: an international multi-centre pragmatic randomised parallel group trial
Acronym STITCH (Trauma)
Serial number at source HTA 07/37/16; 1.0
Study hypothesis A policy of early surgery in patients with traumatic intracerebral haemorrhage will improve outcome at six months compared to a policy of initial conservative treatment.

More details can be found at: http://www.hta.ac.uk/1756
Ethics approval To be submitted as of 19/03/2009
Study design International multi-centre pragmatic randomised parallel group trial
Countries of recruitment Czech Republic, Egypt, Germany, Greece, India, Italy, Latvia, Lithuania, Macedonia, Poland, Russia, Spain, United Kingdom, United States of America

As of 27/03/2009, the list of countries is not yet finalised. Other countries from Africa, Asia, Australasia, Europe, and North and South America are planned to be included.
Disease/condition/study domain Traumatic intracerebral haemorrhage and contusion
Participants - inclusion criteria 1. Both males and females, adults aged 14 or over
2. Evidence of a traumatic intracerebral haemorrhage (TICH) on computed tomography (CT) with a single volume of attenuation significantly raised above that of the background white and grey matter that is in total greater than 10 ml calculated by width times height times length in cm divided by 2
3. Within 24 hours of head injury
4. Clinical equipoise: only patients for whom the responsible neurosurgeon is uncertain about the benefits of either treatment are eligible
Participants - exclusion criteria 1. A significant surface haematoma (epidural haematoma [EDH] or subdural haematoma [SDH]) requiring surgery (The indications for intervention for these patients are already very well defined)
2. More than two separate haematomas fulfilling inclusion criteria
3. If surgery can not be performed within 36 hours of injury or 12 hours of randomisation (whichever is the shorter)
4. Severe pre-existing physical or mental disability or severe co-morbidity which might lead to a poor outcome even if the patient made a full recovery from the head injury (Examples would be a high level of dependence before the injury or severe irreversible associated injury such as complete spinal cord injury)
5. Permanent residence outside a study country preventing follow up
6. Patient and/or relative has a strong preference for one treatment modality
Anticipated start date 01/09/2009
Anticipated end date 28/02/2014
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 840
Interventions Early surgery vs initial conservative treatment
Primary outcome measure(s) Unfavourable outcome will be death or severe disability which will be defined using a prognosis based 8 point Glasgow Outcome Scale.

Total duration of follow-up: 6 months
Secondary outcome measure(s) The following will be assessed at 6 and 12 months:
1. Rankin scale
2. Euroqol EQ-5D
3. Mortality
4. Survival
5. Major Adverse Events (death, pulmonary embolism or deep vein thrombosis, infection, rehaemorrhage)
6. Quality-adjusted life-years (QALYs)
7. Total health care costs
8. Social costs
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications
Contact name Dr  Barbara A  Gregson
  Address STITCH Office
Ward 31 (North Wing)
Newcastle General Hospital
Westgate Road
  City/town Newcastle upon Tyne
  Zip/Postcode NE4 6BE
  Country United Kingdom
  Email trauma.stitch@ncl.ac.uk
Sponsor Newcastle upon Tyne Hospitals NHS Foundation Trust (UK)
  Address Joint Research Office
R&D Department
4th Floor, Leazes Wing
Royal Victoria Infirmary
Queen Victoria Road
  City/town Newcastle upon Tyne
  Zip/Postcode NE1 4LP
  Country United Kingdom
  Email amanda.tortice@nuth.nhs.uk
  Sponsor website: http://www.newcastle-hospitals.org.uk/
Date applied 19/03/2009
Last edited 06/05/2009
Date ISRCTN assigned 27/03/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central